Sinskey Anthony J's Form 4 filing
YIELD10 Bioscience, Inc. (YTEN) · filed Mar 14, 2022
- Accession no.
- 0001179110-22-002211
- Filed
- Mar 14, 2022
- Trade date
- Mar 14, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $6.23K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sinskey Anthony JCIK 0001368753 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $6.23F1 | +$6,230 | 11,309 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reflects the average price per share of the common stock purchased. These shares were purchased in multiple transactions at prices ranging from $6.212 to $6.24 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.
Referenced by the price of 1 transaction in Table I.